Tag: Pharmaceutical industry news
U.K. Restricts Lilly’s Obesity Drug, Pharma Layoffs, and More: Pharmalittle Update
U.K. Restricts Lilly's Obesity Drug to Those in Greatest NeedIn a move to adapt to the rising demand for obesity treatment, the U.K. announced...
Merck Drug Trial and Wegovy in China: Pharmalittle News Update
Good day to you! The Pharmalot team is here, ready to dive into the latest news in the pharmaceutical world. Today, we have some...
Pharmalittle: RFK Jr. Vaccines Scandal & Kids’ Obesity Drug Prescriptions
Good morning and welcome to a new week of work. We hope you had a refreshing weekend because now it's time to get back...
Alzheimer’s Drug Reversal & Bavarian Nordic’s Trump Views: Pharmalittle Update
As the week comes to an end, it's time to start thinking about weekend plans. Whether it's tidying up, taking a trip to see...
GSK Withdraws from BIO, Signaling Major Setback for Lobbying Group
Pharmaceutical company GSK has announced its decision to leave the Biotechnology Innovation Organization (BIO), which is the largest trade group in the biotechnology industry....
Pharmalittle: Updates on Charles River Monkey Shipments and VC Partners in China
Good day to you! The sun is shining, the birds are singing, and the Pharmalot campus is buzzing with activity. We're starting our day...
FDA Oversight of Drug Shortages and AstraZeneca Threats: Pharmalittle News Update
As the week comes to a close, many are looking forward to weekend plans. Whether it's enjoying the outdoors, planning a holiday break, or...
Target: Novo targeting compounded obesity drugs and Amgen ‘at risk’ launchNew Title: Novo Targets...
Hello, everyone! It's great to be here with you today. We hope you're all doing well and ready to dive into some interesting news....
Italian Acquisition and Medicare Advantage Market Growth in the Latest Pharmalittle Update
Good morning! This is Adam Feuerstein reporting from the Pharmalittle campus in Cambridge, Mass., filling in for our regular host Ed. Like Mr. Pharmalot,...
Sanders and Novo Nordisk CEO clash, Roche shifts focus, and more in Pharmalittle
Bernie Sanders, the U.S. Senate health committee chair, has taken a stand against major pharmacy benefit managers in an effort to lower the prices...
Weight Loss Drug Prices and Patent Corrections: Pharmalittle News
Title: Weight Loss Drug Pricing Strategies and Legislative Impact in the Pharmaceutical IndustryAs we approach the end of another work week, it's time to...
FDA Rejects MDMA and Nasal Spray for Allergic Reactions: Pharmalittle Update
Good morning everyone, hope you had a restful weekend and are ready to tackle the new week ahead. As we sip on some refreshing...
BREAKING NEWS
Medicare Coverage of Wegovy Should Include, But Not Negotiate Price
Title: Biden Administration's Decision on Wegovy Medicare Coverage Sparks ControversyPresident Biden's recent announcement regarding the Medicare coverage of Wegovy, a GLP-1 obesity medication, has...
